Jim Simons’s Dimension Therapeutics, Inc DMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-121,000
Closed -$726K 3675
2017
Q3
$726K Buy
121,000
+32,700
+37% +$84.8K ﹤0.01% 2690
2017
Q2
$128K Buy
88,300
+62,400
+241% +$84.8K ﹤0.01% 3059
2017
Q1
$45K Sell
25,900
-28,300
-52% -$75.1K ﹤0.01% 3147
2016
Q4
$236K Buy
+54,200
New +$288K ﹤0.01% 2956

Jim Simons's DMTX Position: Q4 2017 in Review

Jim Simons sold out of Dimension Therapeutics, Inc (DMTX) in Q4 2017, closing a stake of 121,000 shares — an estimated $726K sold.

Jim Simons first reported a position in DMTX in Q4 2016 and held it in 4 quarters. The position peaked at $726K in Q3 2017. 0 funds tracked by Wall St. Rank hold DMTX as of Q4 2017.

  • Jim Simons reported no remaining Dimension Therapeutics, Inc position as of Q4 2017 after selling out during the quarter.
  • Jim Simons sold 121,000 Dimension Therapeutics, Inc shares in Q4 2017, an estimated $726K.
  • Jim Simons first reported a position in Dimension Therapeutics, Inc in Q4 2016 and held it in 4 quarters.
  • Jim Simons's Dimension Therapeutics, Inc position peaked at $726K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2017.

Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.